Braze beats Q2 estimates and raises guidance, shares fall
Braze reported fiscal second-quarter revenue of $227.2 million and non-GAAP EPS of 19 cents, both above consensus, while management raised third-quarter and fiscal 2027 guidance.
Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
16 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
Braze reported fiscal second-quarter revenue of $227.2 million and non-GAAP EPS of 19 cents, both above consensus, while management raised third-quarter and fiscal 2027 guidance.
U.S. stocks ended the week mixed after August jobs data beat expectations, with employers adding 162,000 positions and unemployment holding at 4.1%, boosting bets the Federal Reserve could raise rates in September.
DocuSign reported Q2 revenue of $876 million, up 9% year over year, with a 32% operating margin and about $300 million in free cash flow. It also raised fiscal 2027 ARR guidance and said IAM now accounts for 15.1% of total ARR.
MongoDB reported second-quarter revenue of $771.8 million, up about 30% year on year, and non-GAAP EPS of $1.90, both above consensus. Shares fell 10.82% to $387.25 as analysts cited Atlas growth and AI demand.
Marvell Technology fell nearly 8% premarket after its Q2 results and raised outlook, as investors focused on valuation concerns. The company posted revenue of $2.74 billion and adjusted EPS of 94 cents, and lifted next-quarter guidance.
Datavault AI Inc. (NASDAQ: DVLT) fell Wednesday after reporting second-quarter 2026 revenue of $6.72 million and a 12-cent loss per share, both below estimates.
It’s been a generally successful earnings season for most of the market, as EPS figures remain strong and analysts continue to raise estimates. But not everyone is joining the party. Earnings reports from the following five companies appeared to be strong at first, but all five stocks dropped after reporting. In fact,
Advanced Micro Devices Inc. (NASDAQ: AMD ) is trading into Tuesday’s Q2 earnings with a fresh set of numbers that make the trillion-dollar question impossible to ignore — and options traders are already betting the print itself could be the trigger. AMD stock is climbing into earnings. See the chart and price action he
Investors spent much of the second quarter bracing for an energy shock and fretting over an AI bubble. Corporate earnings have delivered the opposite story so far, with a profit surge running roughly twice as strong as Wall Street expected. PLTR stock is climbing. See the chart and price action here. Oppenheimer report
AXTI beats Q2 EPS and sales estimates
CI reports higher Q2 EPS and revenue
Cigna beats Q2 estimates and raises FY outlook
PI reports higher Q2 earnings and revenue
Boston Scientific Corporation (NYSE: BSX ) stock is trading lower after the company cut its fiscal 2026 outlook, citing pressures on the Watchman and EP markets. Q2 Beats Estimates The medical technology giant reported revenues of $5.442 billion on Wednesday, better than the consensus estimate of $5.361 billion, beatin
WDFC: 15% | WD-40 shares are trading higher after the company reported better-than-expected Q3 financial results. Also, the company raised its FY26 adjusted EPS and sales guidance above estimates. CRCL: 14% | Circle shares are trading higher after the company announced that the U.S. Comptroller of the Currency approved
TD SYNNEX reports fiscal Q2 revenue and earnings above expectations, driven by strong growth in its Hyve AI infrastructure business